Susceptibility of Influenza Viruses to the Novel Cap-Dependent Endonuclease Inhibitor Baloxavir Marboxil

Frontiers in Microbiology - Switzerland
doi 10.3389/fmicb.2018.03026
Full Text
Abstract

Available in full text

Categories
Microbiology
Date
Authors
Publisher

Frontiers Media SA

Related search

Safety, Tolerability, and Pharmacokinetics of the Novel Anti-Influenza Agent Baloxavir Marboxil in Healthy Adults: Phase I Study Findings

Clinical Drug Investigation
MedicinePharmacology
2018English

Pin46 - Cost-Effectiveness Comparison of Baloxavir Marboxil and Laninamivir for the Treatment of Influenza in Japan

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

A Rapid Pyrosequencing Assay for the Molecular Detection of Influenza Viruses With Reduced Baloxavir Susceptibility Due to PA/I38X Amino Acid Substitutions

Influenza and other Respiratory Viruses
EnvironmentalPublic HealthEpidemiologyPulmonaryInfectious DiseasesRespiratory MedicineOccupational Health
2020English

Human-Like Receptor Specificity Does Not Affect the Neuraminidase-Inhibitor Susceptibility of H5N1 Influenza Viruses

PLoS Pathogens
ImmunologyMolecular BiologyVirologyMicrobiologyParasitologyGenetics
2008English

Synthesis and SAR Study of Carbamoyl Pyridone Bicycle Derivatives as Potent Inhibitors of Influenza Cap-Dependent Endonuclease

English

Synthesis and SAR Study of Carbamoyl Pyridone Bicycle Derivatives as Potent Inhibitors of Influenza Cap-Dependent Endonuclease

English

Susceptibility of Influenza A, B, C, and D Viruses to Baloxavir1

Emerging Infectious Diseases
EpidemiologyInfectious DiseasesMicrobiology
2019English

Fitness of Neuraminidase Inhibitor-Resistant Influenza a Viruses

Current Opinion in Virology
Virology
2011English

Susceptibility of Swine to H5 and H7 Low Pathogenic Avian Influenza Viruses

Influenza and other Respiratory Viruses
EnvironmentalPublic HealthEpidemiologyPulmonaryInfectious DiseasesRespiratory MedicineOccupational Health
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy